Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects.
Frey, Sharon E
Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects. [electronic resource] - Vaccine Sep 2014 - 5027-34 p. digital
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1873-2518
10.1016/j.vaccine.2014.07.013 doi
Adjuvants, Immunologic--pharmacology
Aged
Antibodies, Viral--blood
Antibody Formation
Female
Hemagglutination Inhibition Tests
Humans
Influenza A Virus, H3N2 Subtype
Influenza Vaccines--immunology
Influenza, Human--prevention & control
Male
Polysorbates--pharmacology
Single-Blind Method
Squalene--pharmacology
Vaccine Potency
Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects. [electronic resource] - Vaccine Sep 2014 - 5027-34 p. digital
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1873-2518
10.1016/j.vaccine.2014.07.013 doi
Adjuvants, Immunologic--pharmacology
Aged
Antibodies, Viral--blood
Antibody Formation
Female
Hemagglutination Inhibition Tests
Humans
Influenza A Virus, H3N2 Subtype
Influenza Vaccines--immunology
Influenza, Human--prevention & control
Male
Polysorbates--pharmacology
Single-Blind Method
Squalene--pharmacology
Vaccine Potency